LifeVantage is a different kind of company. It's evident in our people, our products and especially in our science. Our science is our foundation. Our science is one of the things that sets us apart from all the rest. At LifeVantage, true science is a priority. Throughout its history, LifeVantage was honored to have Dr. Joe McCord, a world-renowned scientist, co-discoverer of superoxide dismutase and the pioneer of Free Radical Biology, leading the scientific efforts of LifeVantage products. Dr. McCord is at the forefront of today's cutting-edge research and new discoveries related to the groundbreaking new science of Nrf2. Dr. Joe McCord devoted his life to the role of free radicals and the problems associated with aging. One of his discoveries, super oxide dismutase (SOD), is so significant it has been mentioned in over 50,000 per-reviewed publications. For his work, Dr. McCord was awared the Elliott Cresson Medal from The Franklin Institute, presented to distinguished inventors and scientists, putting Dr. McCord in the same company as Pierre and Marie Curie, Alexander Graham Bell, Orville Wright and Henry Ford. Today, LifeVantage is honored to have renowned PhD, Dr. Nathalie Chevreau, our Vice President of Product Development in its research and development department. Dr. Chevreau is at the forefront of today’s research into health, wellness, nutritional supplementation and skin care, as well as continued discoveries related to the groundbreaking new science of Nrf2. We're proud of the scientific studies that back our claims. We're also proud that our scientific studies are peer-reviewed and published. And we're pleased to hold patents on Protandim, the most powerful Nrf2 synergizing supplement on the market. This makes its distribution an exclusive privilege of our independent distributors. Our flagship product, Protandim, has been validated by peer-reviewed studies. The studies have been conducted at some of the world's most respected research institutions including: The Ohio State University LSU University of Colorado Denver Virginia Commonwealth University Colorado State University Texas Tech University The following medical journals have published the results of these studies: Free radical Biology & Medicine Enzyme Research Circulation American Journal of Physiology - Lung Cellular and Molecular Physiology PROTANDIM STUDIES LifeVantage is deeply rooted in science. Science is at the heart of everything we do. Below are summaries of these peer-reviewed studies: Antioxidants for the Treatment of Patients with Severe Angioproliferative Pulmonary Hypertension? Virginia Commonwealth University Antioxid Roedox Signal. 2012. Sept 28. Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge Colorado State University, Fort Collins, CO Oxid Med Cell Longev. 2012;2012:132931. Epub 2012 May 22. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. University of Colorado at Denver Mol Aspects Med. 2011 Aug;32 (4-6):234-46. Epub 2011 Oct 15. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy University of Colorado Denver Health Sciences Center Free Radic Biol Med. 2006 Jan 15;40 (2):341-7. The role of manganese superoxide dismutase in skin cancer Louisiana State University Health Sciences Center Enzyme Res. 2011;2011:409295. Epub 2011 Mar 23. Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway The Ohio State University, Columbus, OH Free Radic Biol Med. 2011 Mar 15;50 (6):700-9. Epub 2010 Dec 15. The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice Texas Tech University Health Sciences Center J Diet Suppl. 2010 Jun 1;7 (2):159-178. Protandim, a fundamentally new antioxidant approach in chemo prevention using mouse two-stage skin carcinogenesis as a model Louisiana State University Health Sciences Center PLoS One. 2009;4 (4): e5284. Epub 2009 Apr 22. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure Virginia Commonwealth University Circulation. 2009 Nov 17;120 (20):1951-60. Epub 2009 Nov 2. The chemo preventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis Louisiana State University Health Sciences Center PLoS One. 2010 Jul 30;5 (7): e11902. Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim University of Colorado Denver Free Radic Biol Med. 2009 Feb 1;46 (3):430-40. Epub 2008 Nov 17. Protandim does not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders. Univ. of Colorado School of Medicine Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302 (7): L688-99. doi: 10.1152/ajplung.00297.2011. Epub 2012 Jan 20. Up regulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Colorado State University, Fort Collins, CO For further information, go to Pubmed.com and look up Protandim. The science behind Protandim is different and unique because LifeVantage Corporation doesn't pay for it. In the world of research, this means that the product and its science must be so compelling that Ph.D.s from universities around the world want to study it and want to spend their own time and money doing it. LifeVantage has a product other people are paying to study! That is unheard of, especially in the supplement industry. - Dr. Skip Campbell


United States

Relevant Industries / Keywords

No information added

Business types

No information added

Company website
https://broadwatergroupinc.lifevantage.com Employees
Number of Employees 5

This company doesn't have any public Opportunities